A Randomized Active-Controlled Study of AMG 162 in Breast Cancer Subjects With Bone Metastasis Who Have Not Previously Been Treated With Bisphosphonate Therapy.
Phase of Trial: Phase II
Latest Information Update: 15 Oct 2016
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates
- Indications Breast cancer; Cancer metastases
- Focus Pharmacodynamics
- Sponsors Amgen
- 10 Jun 2017 Biomarkers information updated
- 16 Jun 2009 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
- 01 Jun 2008 Results presented at the Annual Meeting of the American Society of Clinical Oncology 2008.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History